🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective randomised trial of 3 influenza vaccine formula...
Status
Completed
Location
National Centre for Infectious Diseases (NCID)
Start Date
2022-09-29
Trial ID
NCT05479370
Treatments Being Tested
This is a Phase 1, single-site, open-label, comparator-controlled dose esca...
Status
Completed
Location
Duke Vaccine and Trials Unit
Start Date
2023-04-05
Trial ID
NCT05755620
A total of 18,000 eligible subjects (or 6,000 subject distributed evenly be...
Status
Active Not Recruiting
Location
Naval Medical Center San Diego
Start Date
2018-11-06
Trial ID
NCT03734237
The primary objective of this study is to retrospectively characterize the ...
Status
Completed
Location
Kaiser Permanente Vaccine Study Center
Start Date
2015-11
Trial ID
NCT02600585
Treatments Being Tested
This randomized, double-blinded trial will assess humoral immune responses ...
Status
Completed
Location
Hospital Nacional Arzobispo Loayza
Start Date
2022-11-04
Trial ID
NCT06054269
Treatments Being Tested
Licensed influenza vaccines are manufactured with a variety of technologies...
Status
Completed
Location
Marshfield Clinic - Marshfield Center
Start Date
2018-07-30
Trial ID
NCT03598439
Treatments Being Tested
This randomized, open-label trial will assess humoral and cell-mediated imm...
Status
Completed
Location
Kaiser Permanente Northwest
Start Date
2018-09-12
Trial ID
NCT03722589
Treatments Being Tested
This randomized, open-label, active-controlled trial will assess humoral im...
Status
Completed
Location
Soroka Medical Center
Start Date
2019-10-31
Trial ID
NCT04523324
Treatments Being Tested
The main purpose of the study is to evaluate the safety, reactogenicity, an...
Status
Completed
Location
Washington University in St. Louis
Start Date
2022-11-02
Trial ID
NCT05606965
The purpose of this study was to demonstrate the non-inferior HAI immune re...
Status
Terminated
Location
Birmingham Pediatric Associates Site Number : 8400023
Start Date
2022-11-10
Trial ID
NCT05513391
Treatments Being Tested